Drug classification system for assessment of association with DIP.

NIAID Data Ecosystem2026-03-11 收录

数据链接：

https://figshare.com/articles/dataset/Drug_classification_system_for_assessment_of_association_with_DIP_/12147213 数据链接链接失效反馈

官方服务：

资源简介：

Drug classification system for assessment of association with DIP.

创建时间：

2020-04-17

药品不良反应数据库

不良药物反应

用药监测

为公开报道的临床用药出现的药物不良反应。内容包括：患者信息：性别、年龄等；药品信息：药品名称、成分、剂型、规格、用法用量、治疗类别、适应症、生产厂家等；用药情况：用药原因、给药途径等；药品不良反应情况：不良反应发生时间、症状、不良反应后果等；药品不良反应治疗情况：采取措施、治疗效果等。适用于药物研发、科研教育、医疗卫生和政府管理等方面。

中国科技资源共享网2026-07-12 更新290

DataSheet1_Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Advanced Non-small Cell Lung Cancer: A Network Meta-Analysis of Randomized Clinical Trials.docx

免疫治疗安全性

不良药物反应

Objective: This network meta-analysis will provide a complete toxicity profile, toxicity profile, and safety ranking of immune checkpoint inhibitors (ICIs) for treatment of advanced non-small cell lun

NIAID Data Ecosystem20

Table of adverse drug reactions.

药物安全监测

不良药物反应

Table of adverse drug reactions.

NIAID Data Ecosystem10

Genetic, clinical, and biomarker correlates of EGFR inhibitor-related rash. Genetic, clinical, and biomarker correlates of EGFR inhibitor-related rash

不良药物反应

EGFR抑制剂

Dermal fibroblasts that were cultured from skin biopsy samples were treated for three days with either 1µM of erlotinib, 1µM of DMSO (vehicle), or no treatment. The cells were harvested on the fourth

NIAID Data Ecosystem30

Analysis of adverse drug reactions induced by camrelizumab in our hospital and literature review

不良药物反应

用药安全

Objective: To analyze the situation and clinical characteristics of adverse drug reactions (ADRs) induced by camrelizumab, and provide references for clinical medication safety. Methods: Adverse drug

DataCite Commons2025-04-27 更新20

Drug classification system for assessment of association with DIP.

资源简介：

相关数据集